Patents by Inventor Tom Chu

Tom Chu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quick Release Axle Slider, A Motorcycle Crash Protection Device
    Publication number: 20180281884
    Abstract: A quick release axle slider to be used with a motorcycle may include a slider base; a first magnetic ring to cooperate with the slider base; a rod to connect to the first magnetic ring; and a first fastener to extend through the slider base through the first magnetic ring and to connect to the rod.
    Type: Application
    Filed: April 2, 2018
    Publication date: October 4, 2018
    Inventor: Tom Chu
  • Prediction of HCV Viral Kinetics in Interferon-Free Treatment
    Publication number: 20120196272
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-free treatment.
    Type: Application
    Filed: July 29, 2011
    Publication date: August 2, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Tom Chu, Uri A. Lopatin, Nancy Shulman
  • Prediction of Early Virological Response in HCV Treatment
    Publication number: 20120094284
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 19 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
    Type: Application
    Filed: April 11, 2011
    Publication date: April 19, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Uri Lopatin, Tom Chu, Laurent Essioux, Soren Germer, Nancy Shulman, James A. Thommes
  • Single Nucleotide Polymorphisms That Predict HCV Treatment Outcomes
    Publication number: 20120094389
    Abstract: The present invention is based on the discovery of associations that exist between single nucleotide polymorphisms (SNPs) on chromosome 4 and virological outcomes in a diverse population of patients with hepatitis C virus (HCV) who received interferon-based treatment.
    Type: Application
    Filed: April 11, 2011
    Publication date: April 19, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Uri Lopatin, Tom Chu, Laurent Essioux, Soren Germer, Nancy Shulman, James A. Thommes
  • Motorcycle assembly
    Publication number: 20110248472
    Abstract: A device to protect the frame of the motorcycle may include An engine to drive the motorcycle, a frame to support the motorcycle, a left bracket to mount on a left side of the motorcycle between the frame and engine, and a right bracket to mount on the right side of the motorcycle between the frame and engine. The left bracket may be connected to a first frame slider, and the right bracket may be connected to a second frame slider. The first frame slider may extend beyond the frame of the motorcycle, and the second frame slider may extend beyond the frame of the motorcycle. The left bracket may include a first portion and the left bracket may include a second portion connected to the first portion. The left bracket may include a third portion connected to the second portion and the third portion may include a first side wall, a second side wall and a top wall to connect to the frame.
    Type: Application
    Filed: April 12, 2010
    Publication date: October 13, 2011
    Inventor: Tom Chu
  • GMG-3 GMG-4 and GMG-6 polynucleotides and polypeptides and uses thereof
    Patent number: 7326678
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Grant
    Filed: January 15, 2002
    Date of Patent: February 5, 2008
    Assignee: Serono Genetics Institute S.A.
    Inventors: Mary Ruth Erickson, Barbara A. Chicca, Bernard Bihain, Hiroaki Tanaka, Tom Chu, Deno P. Dialynas, Aaron Scalia
  • Gmg-3 gmg-4 and gmg-6 polynucleotides and polypeptides and uses thereof
    Publication number: 20050239696
    Abstract: The present invention relates to the field of metabolic research. Metabolic disorders, such as obesity, are a public health problem that is serious and widespread. GMG-3, GMG-4, Cluster 1, GMG-6A, or GMG-6B polypeptides have been identified that are beneficial in the treatment of metabolic disorders. These compounds should be effective for reducing body mass and for treating metabolic-related diseases and disorders. These metabolic-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.
    Type: Application
    Filed: January 15, 2002
    Publication date: October 27, 2005
    Applicant: Genset S.A.
    Inventors: Mary Erickson, Barbara Chicca, Bernard Bihain, Hiroaki Tanaka, Tom Chu, Deno Dialynas, Aaron Scalia